tetramethylpyrazine has been researched along with angiotensin ii in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, ZQ; Wang, SR; Zhu, LQ | 1 |
| Chan, P; Chen, CH; Cheng, TH; Kao, PF; Lee, WS; Liu, JC; Yang, HY | 1 |
| Lu, J; Qu, ZL; Ren, XY; Ruan, QR; Zhu, DH; Zhu, M | 1 |
| Cheng, TH; Chou, YH; Hong, HJ; Wong, KL; Wu, KC; Wu, RS | 1 |
| Jiang, LD; Lu, XY; Qin, Y; Wang, SR; Wu, AM; Zhang, DM; Zhu, LQ | 1 |
| Gao, MH; Li, B; Ren, SR; Zhang, B; Zhang, L | 1 |
| Sun, YK; Wang, SR; Yu, Y | 1 |
| Nie, H; Ran, X; Zeng, Z | 1 |
| Cheng, M; Han, L; Li, M; She, T; Shi, C; Yu, L | 1 |
| Chen, L; Kong, D; Lian, N; Lu, Y; Wu, X; Zhang, F; Zhang, X; Zheng, S | 1 |
| He, GW; Liu, XC; Mak, SK; Sun, WT; Yang, Q; Yu, CM | 1 |
| Deng, F; Fang, S; Zhang, B; Zhang, Y | 1 |
12 other study(ies) available for tetramethylpyrazine and angiotensin ii
| Article | Year |
|---|---|
[Effect of danshensu and ligustrazine on related genes of myocardial hypertrophy induced by angiotensin II].
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Drugs, Chinese Herbal; Female; Lactates; Male; Myocytes, Cardiac; Pyrazines; Rats; Rats, Wistar; RNA, Messenger | 2005 |
Tetramethylpyrazine downregulates angiotensin II-induced endothelin-1 gene expression in vascular endothelial cells.
Topics: Angiotensin II; Antioxidants; Blotting, Northern; Blotting, Western; Cells, Cultured; Chloramphenicol O-Acetyltransferase; Down-Regulation; Endothelial Cells; Endothelin-1; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Humans; Phosphorylation; Promoter Regions, Genetic; Pyrazines; Reactive Oxygen Species; Recombinant Fusion Proteins; RNA, Messenger; Superoxides; Transfection | 2005 |
Tetramethylpyrazine inhibits agiontensin II-induced nuclear factor-kappaB activation and bone morphogenetic protein-2 downregulation in rat vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Atherosclerosis; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Immunohistochemistry; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Pyrazines; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 2007 |
Tetramethylpyrazine inhibits angiotensin II-increased NAD(P)H oxidase activity and subsequent proliferation in rat aortic smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Cell Proliferation; Cells, Cultured; DNA; Endothelin-1; Extracellular Signal-Regulated MAP Kinases; Male; Muscle, Smooth, Vascular; NADPH Oxidases; Pyrazines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Transcription Factor AP-1; Vasodilator Agents | 2007 |
[Effects of tetramethylpyrazine on angiotensin II -induced proliferation and type I collagen synthesis of rat cardiac fibroblasts].
Topics: Angiotensin II; Animals; Animals, Newborn; Cell Proliferation; Collagen Type I; Fibroblasts; Myocardium; Pyrazines; Rats, Sprague-Dawley | 2009 |
[Effect of tetramethylpyrazine on JAK-STAT signal transduction in cardiomyocyte hypertrophy].
Topics: Angiotensin II; Animals; Cells, Cultured; Hypertrophy; Janus Kinases; Myocytes, Cardiac; Pyrazines; Rats; Rats, Wistar; Signal Transduction; STAT Transcription Factors | 2011 |
[Effects of ligustrazine on the mitochondrial structure and functions in the process myocardial hypertrophy].
Topics: Angiotensin II; Animals; Cardiomyopathy, Hypertrophic; Cells, Cultured; Electron Transport Complex IV; Mitochondria, Heart; Monoamine Oxidase; Myocytes, Cardiac; Pyrazines; Rats; Rats, Sprague-Dawley | 2012 |
[Effect of tetramethylpyrazine on Nogo gene regulation of the proliferation in cardiac fibroblast].
Topics: Angiotensin II; Animals; Animals, Newborn; Cell Proliferation; Cells, Cultured; Collagen Type I; Fibroblasts; Gene Expression Regulation; Male; Myelin Proteins; Myocytes, Cardiac; Nogo Proteins; Pyrazines; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2012 |
Tetramethylpyrazine inhibits angiotensin II-induced cardiomyocyte hypertrophy and tumor necrosis factor-α secretion through an NF-κB-dependent mechanism.
Topics: Angiotensin II; Animals; Cell Enlargement; Cells, Cultured; Enzyme Activation; Gene Expression Regulation; Hypertrophy; Myocytes, Cardiac; NF-kappa B; Protein Biosynthesis; Protein Transport; Pyrazines; Rats; Signal Transduction; Tumor Necrosis Factor-alpha | 2013 |
Tetramethylpyrazine inhibits angiotensin II-induced activation of hepatic stellate cells associated with interference of platelet-derived growth factor β receptor pathways.
Topics: Angiotensin II; Animals; Apoptosis; Cell Division; Cell Proliferation; Flow Cytometry; G2 Phase; Hepatic Stellate Cells; Male; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyrazines; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor beta; TOR Serine-Threonine Kinases | 2014 |
Tetramethylpyrazine suppresses angiotensin II-induced soluble epoxide hydrolase expression in coronary endothelium via anti-ER stress mechanism.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin II; Animals; Cells, Cultured; Coronary Vessels; Dose-Response Relationship, Drug; Endoplasmic Reticulum Stress; Endothelial Cells; Epoxide Hydrolases; In Vitro Techniques; Pyrazines; Sus scrofa; Tunicamycin; Vasodilation; Vasodilator Agents | 2017 |
Ligustrazine prevents basilar artery remodeling in two-kidney-two-clip renovascular hypertension rats via suppressing PI3K/Akt signaling.
Topics: Angiotensin II; Animals; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Endothelin-1; Hypertension, Renovascular; Ligation; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Pyrazines; Rats, Sprague-Dawley; Renal Artery; Signal Transduction; Temporal Arteries; Vascular Remodeling | 2020 |